UK Biopharma Looks To Learn From Flagship Pioneering And Make ‘Bigger Leaps’

 
• By Andrew McConaghie

UK life sciences sector leaders are pleased to have attracted Flagship Pioneering to invest in the country, as its CEO Noubar Afeyan emphasizes that its initial focus would be on early ‘experiments’ in innovation and cultural bridge-building.

Noubar Afeyan
Flagship Pioneering CEO Noubar Afeyan (right) with GSK chairman Sir Jon Symonds. • Source: Source: Flagship Pioneering

More from Business

More from Scrip